Full Text
HTA132 Evaluating High-Cost Gene Therapies for Noncancer Conditions: Insights From NICE's Standard Appraisal Process

Abstract

Authors

Naomi Stapleton Alexandra Kumichel Maria Dvorkina

Back to Volume 28, Supplemental Issue 12S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×